We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Keyhole Bowel Cancer Surgery is Both Safe and Effective

By HospiMedica International staff writers
Posted on 23 Nov 2010
Laparoscopic surgery is a safe and effective way of removing bowel tumors and it should be offered to all patients undergoing surgery for colorectal cancer, according to a new study. More...


Researchers at the University of Leeds (United Kingdom) reported the results of the 5-year follow‐up of the laparoscopically assisted versus open surgery for colorectal cancer (CLASICC) trial, a multicentre study that involved 400 patients with colon cancer and another 400 with rectal cancer; the trial drew on patients from 27 hospitals across the United Kingdom, and included a detailed analysis of all tissue samples that were removed to assess the quality of surgery. Five‐year outcomes were analyzed and included overall and disease‐free survival, and local, distant, and wound and port‐site recurrences. Two exploratory analyses were performed to evaluate the effect of age (older and younger than 70 years) on overall survival between the two groups, and the effect of the learning curve.

The results showed that no differences were found between laparoscopically assisted and open surgery in terms of overall survival, disease‐free survival, and local and distant recurrence; wound and port‐site recurrence rates in the laparoscopic arm also remained stable at 2.4%. Conversion to open surgery was associated with significantly worse overall but not disease‐free survival, which was most marked in the early follow‐up period. The effect of surgery did not differ between the age groups, and surgical experience did not affect the 5‐year results. The researchers concluded that the use of laparoscopic surgery to maximize short‐term outcomes does not compromise the long‐term oncologic results. The study was published in the November 2010 issue of the British Journal of Surgery (BJS).

"There is still a body of surgeons who are skeptical about laparoscopic colorectal cancer surgery and particularly laparoscopic rectal surgery. These long-term follow-up results should now help to convince any remaining skeptics that the minimally invasive technique is safe and effective for most patients with colorectal cancer,” said lead author David Jayne, M.D., a senior lecturer in surgery at the University of Leeds.

"Surgery remains the most important of the methods of treatment of bowel cancer and this study confirms that tumors can be removed equally well by keyhole surgery as by standard surgery,” added coauthor Professor Phil Quirke, M.D., of the department of Pathology. "We must, however, continue to strive for surgical excellence through audit of both types of surgery and by exploration of new techniques, such as robotic surgery.”

Related Links:

University of Leeds





Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.